Jiangsu Vcare

Nanjing, China · Founded 2010 · Privately Held (backing)

Developer of innovative drugs designed to treat cardiovascular and cerebrovascular, tumors, endocrine, and other areas of chronic diseases. Jiangsu Vcare is based in Nanjing, China and was founded in 2010. Its last reported valuation was $162 million in Feb 2021. It has raised $225 million.

Last reported valuation

$162.4M

Oct 2026

Priced at

—

Total raised

$225.4M

Last round

—

How much has Jiangsu Vcare raised?

$225.4Macross 0 recorded rounds

Free account

More of Jiangsu Vcare with a free account

·The complete investor list: 17 names
·Watch Jiangsu Vcare: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Jiangsu Vcare investors

17 investors are on record for Jiangsu Vcare, including Zijin Hi-Tech Venture Capital, CMG SDIC Fund, Nanjing Innovation Capital Group and Hubei Yangtze River Industrial Investment Group.

For fundraisers

Raising for a company like Jiangsu Vcare?

17 investors have backed Jiangsu Vcare.

See all 17 investors →

Frequently asked about Jiangsu Vcare

How much has Jiangsu Vcare raised?: Jiangsu Vcare has raised $225.4M in total across 0 recorded funding rounds.